Login / Signup

Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International Study.

Michael Y HeneinGiulia Elena MandoliMaria Concetta PastoreNicolò GhionzoliFouhad HassonMuhammad K NisarMohammed IslamFrancesco BanderaMassimiliano M Marrocco-TrischittaIrene BaroniAlberto Maria LanzoneLuca RossiAndrea BiagiRodolfo CitroMichele CiccarelliAngelo SilverioGiulia BiagioniJoseph A MoutirisFederico VancheriGiovanni MazzolaGiulio GeraciLiza ThomasMikhail AltmanJohn PernowMona AhmedCiro SantoroRoberta EspositoGuillem CasasRubén Fernández-GaleraMaribel GonzalezJose Rodriguez PalomaresIbadete BytyciFrank Lloyd DiniPaolo CameliFederico FranchiGani BajraktariLuigi Paolo BadanoMatteo Cameli
Published in: Journal of clinical medicine (2021)
Our findings, derived from a multicenter data collection study, suggest the routine use of biomarkers, such as cardiac troponin and serum creatinine, for in-hospital prediction of CV events in patients with COVID-19.
Keyphrases
  • healthcare
  • sars cov
  • adverse drug
  • clinical trial
  • left ventricular
  • metabolic syndrome
  • big data
  • deep learning
  • atrial fibrillation